🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7604811

Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601114

Apparatus and method for enhancing tissue repair in mammals

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598077

Compositions and methods for enhancing differential expression

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598225

Generation of immune response to prostate-specific antigen (PSA)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7595191

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589181

Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585841

Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585667

Negative strand RNA virus replicon

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582430

Immunoliposome-nucleic acid amplification (ILNAA) assay

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582680

Methods and compositions for treating mammalian spinal cord injuries

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579006

Method of treating immune pathologies with low dose estrogen

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579453

Variants of human taste receptor genes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576050

GLP-1 exendin-4 peptide analogs and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7575742

Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572887

Gene expressed in prostate cancer, methods and use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7574340

Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572771

Multi-domain amphipathic helical peptides and methods of their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566465

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and poten

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563766

Methods and compositions for the promotion of a hair growth utilizing actin binding peptid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted